<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7344049\results\search\country\results.xml">
  <result pre="8945 4455State Key Laboratory of Quality Research in Chinese Medicine," exact="Macau" post="Institute for Applied Research in Medicine and Health, Macau"/>
  <result pre="Medicine, Macau Institute for Applied Research in Medicine and Health," exact="Macau" post="University of Science and Technology, [2], [3], epub: 2020-7-7pmc-release:"/>
  <result pre="resulting in fatal diseases in humans [3]. In December 2019," exact="China" post="faced another destructing SARS-CoV-2 outbreak leading to major health"/>
  <result pre="reported at the end of December 2019 from Wuhan Hubei," exact="China" post="[4]. The causative agent was announced by Chinese authority"/>
  <result pre="supported by studies found 500 CoVs identification in bats in" exact="China" post="[8]. Bats are exceptional food available in a few"/>
  <result pre="effective treatment is available for COVID-19, but in this regard," exact="China" post="has approximately two thousand old histories of using traditional"/>
  <result pre="effect on the lethal infection of a Hemagglutinating virus of" exact="Japan" post="(HVJ), as well as has antiviral activity on the"/>
  <result pre="medicine that was approved for the treatment of sepsis in" exact="China" post="[30]. XBJI shows a protective effect in patients with"/>
  <result pre="of 40% infected individuals having acute respiratory distress syndrome in" exact="France" post="while 62.2% H7N9 avian influenza-infected patients were treated with"/>
  <result pre="modulating the expression of pro-inflammatory cytokines and is approved in" exact="Russia" post="and China for their inhibitory effects on SARS-CoV-2 [88]."/>
  <result pre="expression of pro-inflammatory cytokines and is approved in Russia and" exact="China" post="for their inhibitory effects on SARS-CoV-2 [88]. Interestingly in"/>
  <result pre="granules (approval number of State Food and Drug Administration of" exact="China" post="(SFDA) Z20160001), Lianhua Qingwen granules (SFDA approval number Z20100040),"/>
  <result pre="have been approved by the National Medical Products Administration of" exact="China" post="and have proved inclusion for the treatment of the"/>
  <result pre="the current outbreak convalescent plasma therapy in uncontrolled studies in" exact="China" post="indeed indicated a beneficial treatment for patients on mechanical"/>
  <result pre="FDCT grants from the Science and Technology Development Fund of" exact="Macao" post="(Project code: 003/2018/A1 grant to F.X.X). Availability of data"/>
  <result pre="Li X, Yang B, Song J, et al. for the" exact="China" post="Novel Coronavirus Investigating and Research Team (2020) A novel"/>
  <result pre="an epitope-based synthetic long peptide vaccine to counteract the novel" exact="China" post="Coronavirus (2019-nCoV). 2020. 76.SkalickovaSHegerZKrejcovaLPekarikVBastlKJandaJet al.Perspective of use of antiviral"/>
  <result pre="2019-nCoV infected patients linked to viral loads and lung injurySci" exact="China" post="Life Sci.2020111 85.LiuZGuoZWangGZhangDHeHLiGet al.Evaluation of the efficacy and safety"/>
 </snippets>
</snippetsTree>
